Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-56.54	16.93	38.96
Graham Fair Price	41.42	6.59	4.66
PEG	-94.06	0.04	0.61
Price/Book	-15.15	0.11	0.13
Price/Cash Flow	-19.85	6.10	7.61
Prices/Earnings	-57.58	3.40	8.00
Price/Sales	-58.73	1.83	4.44
Price/FCF	-19.85	6.10	7.61
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	2.14	0.57	0.56
Operating Margin	3.22	0.48	0.47
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	89.89
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.02	-80.86
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.09	1.12	2.97
EPS QOQ	0.13	0.94	614.16
FCF QOQ	3.34	0.06	-98.25
Revenue QOQ	-0.24	1.06	345.11
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	794.24	397.12	-50.00
Days Sales Outstanding (DSO)	3.33	3.98	19.73
Inventory Turnover	0.11	0.23	100.00
Debt/Capitalization	0.36	0.36	0.30
Quick Ratio	1.18	1.19	0.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	15.62	15.62	< 0.005
Cash	2.53	2.53	< 0.005
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	0.26	0.28	5.86
Revenue	0.45	0.92	105.61
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.20	2.20	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	29.57	13.35	-54.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating